Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.
about
Many multiple myelomas: making more of the molecular mayhemMolecular pathogenesis of multiple myeloma: basic and clinical updatesThe myeloma stem cell concept, revisited: from phenomenology to operational termsPhenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myelomaDosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.Germinal center B-cells resist transformation by Kras independently of tumor suppressor ArfInherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival.Molecular pathogenesis of multiple myeloma and its premalignant precursor.Stemness of B-cell progenitors in multiple myeloma bone marrow.Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells.The genetic architecture of multiple myeloma.Emerging pathways as individualized therapeutic target of multiple myeloma.Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy.Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma.A replicative self-renewal model for long-lived plasma cells: questioning irreversible cell cycle exit.Is it time for preemptive drug treatment of asymptomatic (smoldering) multiple myeloma?Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in manMyeloma Propagating Cells, Drug Resistance and Relapse.Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.Mechanisms of Resistance in Multiple Myeloma.CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype.Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.Successful Autologous Hematopoietic Stem Cell Transplantation Followed by Bortezomib Maintenance in a Patient with Relapsed CD138-low Multiple Solitary Plasmacytomas Harboring a 17p Deletion.Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis
P2860
Q26852892-50378ECD-A754-4F7D-AB95-200A31507E22Q27026205-5C4449AE-D036-4230-A661-348CC69DC7F7Q28076070-9748DB10-7A4A-45E5-A157-B977531CE74CQ28731827-0E78C2D3-48EB-4A4B-9456-4F0097EEF854Q33400076-A6339868-5669-4819-96AF-ADB0D1EF3123Q34795181-A46F8D5E-162B-483E-BD56-E65F827A57A6Q36137122-BA56C68F-82B7-4AD6-BCB7-F2993D45142CQ36290238-5F7A667F-5B57-45ED-8A3B-695B405A38E5Q36405908-932540B8-1E01-4237-AAE8-9DDCB9FF3581Q36525196-51F85192-5531-4467-AEE2-01967D427952Q37718836-3113E32C-8BA0-4089-B448-43545D903E39Q38112176-7E02108C-650D-4D03-8804-B775503CD5AEQ38133611-AA1EF1CB-F757-4328-A34A-44B625F41816Q38151195-9686AEE8-9DF3-464D-9733-FBFFBE24C4C2Q38175395-6ED97ED8-F0D2-4B1A-AF23-C07BCA96EF12Q38190593-BB3D583D-E3A0-4453-8538-F1A8663E3454Q38309297-9F539FAC-F399-4624-BFFE-498B8BE3A109Q38572771-2329BE4E-875F-480B-8059-F00F682F0422Q38932298-50582E04-26BE-40DC-871F-0C7FC75CC5D6Q39158457-81A09525-68EC-4ADC-84AE-B076ACDC848FQ39185604-D6A695F1-5F37-4057-8465-773D5C477E72Q39399792-6A9D39DD-4EFF-4C76-9268-729B5E86EB46Q39653218-3077BE69-EC94-42B3-9D15-5159CCC51C6EQ47707509-84AE3768-AF72-4FC6-AEBE-920218DDC17DQ50588462-A3B24D13-24BB-443C-89C5-10BED1B7B408Q52579654-741270E2-8F56-495A-9BEE-7EB688705615Q58698408-17C1990F-B5A4-44FC-8A7F-FFF3E7B46F3E
P2860
Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of translocatio ...... atients with multiple myeloma.
@ast
Identification of translocatio ...... atients with multiple myeloma.
@en
type
label
Identification of translocatio ...... atients with multiple myeloma.
@ast
Identification of translocatio ...... atients with multiple myeloma.
@en
prefLabel
Identification of translocatio ...... atients with multiple myeloma.
@ast
Identification of translocatio ...... atients with multiple myeloma.
@en
P2093
P2860
P1433
P1476
Identification of translocatio ...... atients with multiple myeloma.
@en
P2093
Gitte B Kerndrup
Inger Marie Dahl
Jacob Haaber
Lene M Knudsen
Marianne Lodahl
Michael Kuehl
Thomas Rasmussen
P2860
P304
P356
10.3324/HAEMATOL.2010.024778
P577
2010-05-29T00:00:00Z